TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Biosite AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
12,971
|
11,624
|
11,942 |
Financial expenses |
10
|
300
|
685 |
Earnings before taxes |
1,985
|
962
|
1,384 |
EBITDA |
1,834
|
1,100
|
1,842 |
Total assets |
4,650
|
4,097
|
5,569 |
Current assets |
4,477
|
3,728
|
4,800 |
Current liabilities |
1,985
|
1,549
|
1,523 |
Equity capital |
2,255
|
2,100
|
3,509 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
16
|
20
|
19 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
48.5%
|
51.3%
|
63.0% |
Turnover per employee |
811
|
581
|
629 |
Profit as a percentage of turnover |
15.3%
|
8.3%
|
11.6% |
Return on assets (ROA) |
42.9%
|
30.8%
|
37.2% |
Current ratio |
225.5%
|
240.7%
|
315.2% |
Return on equity (ROE) |
88.0%
|
45.8%
|
39.4% |
Change turnover |
1,313
|
650
|
-9,795 |
Change turnover % |
11%
|
6% | |
Chg. No. of employees |
-4
|
1
|
-13 |
Chg. No. of employees % |
-20%
|
5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.